Viking Therapeutics, Inc.

VKTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$28.99-1.26%

2026-09-18

Financials

Valuation Metrics

Viking Therapeutics, Inc.'s Market Cap is $3.37B. At end of 2025 it was $4.01B. Ranked #1632 of 3,121 in US market (top 52%), #577 of 1,463 on NASDAQ (top 39%), #96 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 36%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$3.37B	US#1,632/3,121 Sec#96/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-535M	US—/3,121 Sec—/266
Total Assets	$522M	US#2,754/3,121 Sec#162/266
Net Assets	$408M	US#2,367/3,121 Sec#132/266
Value
P/B	8.24x	US#2,549/3,121 Sec#184/266
FCF Yield	-12.43%	US—/3,121 Sec—/266
Profitability
ROE	-130.98%	US#2,817/3,121 Sec#210/266
Financial Health
Debt Ratio	27.82%	US#306/3,121 Sec#97/266
Total Debt	$4M	US#2,925/3,121 Sec#222/266
FCF	$-418M	US#2,886/3,121 Sec#247/266
Cash	$126M	US#2,065/3,121 Sec#151/266
Current Ratio	4.72x	US#511/3,121 Sec#154/266
Performance
1Y Return	11.33%	US#984/3,121 Sec#144/266
1M Return	-19.43%	US#2,625/3,121 Sec#200/266
From 52W High	-32.82%	US#2,157/3,121 Sec#171/266
1Y MDD	-35.53%	US#1,773/3,121 Sec#119/266
Trading
Volume	2,587,330 shares	US#803/3,121 Sec#82/266
Trading Value	$75M	US#1,121/3,121 Sec#83/266
Per Share
EPS	$-4.61	US—/3,121 Sec—/266
BPS	$3.52	US#2,421/3,121 Sec#153/266